Klaus Veitinger

OrbiMed is a healthcare-dedicated investment firm focusing on biopharmaceuticals for medical devices and diagnostics.

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.

Raised $61,275,255.00 from RiverVest, OrbiMed and U.S. Venture Partners.

Alpheus Medical provides a novel sonodynamic therapy platform targeting solid body cancers.

Raised $30,000,000.00 from BrightEdge Fund, Action Potential Venture Capital, Medtech Convergence Fund, SV Health Investors, OrbiMed, Action Potential Venture Capital, BrightEdge Fund, SV Health Investors, OrbiMed and National Brain Tumor Society.

A private biopharmaceutical company .

Raised $105,000,000.00 from Samsara BioCapital, Vivo Capital, RTW Investments, Marshall Wace, 5AM Ventures, venBio Partners and OrbiMed.

Cure Rare Disease is a biotechnology company.

Tricida operates in the healthcare industry focusing on pharmaceutical business.

Raised $624,014,244.00 from Hercules Capital.